Masimo Corp (MASI) Company Profile & Statistics

Masimo Corp
MASI
(Nasdaq - US)
Open
176.38
+3.42 (+1.98%)
in:usd•As of: Nov 25, 2024 15:07 UTC -5
Open
175.00
High
178.17
Low
175.00

About Masimo Corp

CEO

Joe Kiani

Headquarters

52 discovery

irvine, ca 92618, united states

Auditor

GRANT THORNTON LLP

Employees

5,200

Share Holders

Website

www.masimo.com

Industry

medical specialties

Sector

health technology

Company Overview

Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.

Masimo Corp Statistics

Valuation Measures

Market Capitalization ²	9.44B
Enterprise Value	10.02B
Enterprise Value/EBITDA (ttm)	43.00
Price to Earnings Ratio (ttm)	44.81
Price to Book (mrq)	6.33
Price to Sales (ttm)	4.53
Price to Cash (ytd)	30.01

Profitability

Gross Margin (ttm)	50.10%
Operating Margin (ttm)	10.20%
Profit Margin (ttm)	3.79%
Return on Equity (ttm)	14.98%
Return on Invested Capital (ttm)	3.57%
Return on Assets (ttm)	6.95%

Income Statement

Revenue (ttm)	2.04B
Revenue Per Share (ttm)	38.15
Gross Profit (ttm)	1.02B
EBITDA (ttm)³	233.00M
Net Income Avi to Common (ttm)	78.60M
Diluted EPS (ttm)	1.45

Share Statistics

Beta (5Y Monthly)	0.97
52-Week Change	86.27%
S&P500 52-Week Change	31.51%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	53.54M
Dividend Yield	0.00%
Float ⁴	48.35M
% Held by Insiders	9.70%
% Held by Institutions	85.96%

Balance Sheet

Total Cash (mrq)	158.50M
Total Cash Per Share (mrq)	2.96
Total Debt (mrq)	733.20M
Total Debt/Equity (mrq)	50.11%
Current Ratio (mrq)	2.01%
Quick Ratio (mrq)	1.11%
Book Value Per Share (mrq)	27.35

Cash Flow

Operating Cash Flow Per Share (ytd)	2.69
Free Cash Flow (ytd)	134.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Masimo Corp

Trade With A Regulated Broker